Skip to main content

Peer Review reports

From: Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1

Original Submission
21 Mar 2017 Submitted Original manuscript
30 Jun 2017 Reviewed Reviewer Report - George Joseph Hutton
4 Aug 2017 Reviewed Reviewer Report - Roberta Lanzillo
4 Oct 2017 Author responded Author comments - Anthony Traboulsee
Resubmission - Version 2
4 Oct 2017 Submitted Manuscript version 2
2 May 2018 Reviewed Reviewer Report - Francesco Patti
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
30 Aug 2018 Editorially accepted
14 Sep 2018 Article published 10.1186/s12883-018-1145-x

You can find further information about peer review here.

Back to article page